Table 1.
Age, year (y) month (m) | Suspected diagnoses | Methods | |
---|---|---|---|
Patient 1 | 0 y 9 m | Hypercortisolism | Cortisol profile and dexamethasone suppression test |
Hypothyroidism | Thyrotropin-releasing hormone stimulation test | ||
Growth hormone deficiency | Insulin hypoglycaemia test and radiography | ||
Brain tumour/brain malformation | Sonography | ||
1 y 10 m | Prader-Willi syndrome | MS-MLPA | |
Chromosome aberrations | Chromosome analysis | ||
Congenital leptin deficiency | Leptin ELISA | ||
2 y 6 m | Brain tumour/brain malformation | MRI | |
Pituitary tumour | MRI | ||
Hypercortisolism | Urinary cortisol profile | ||
Disorder of the adipocyte differentiation | In vitro functional examination | ||
Adrenal insufficiency | Adrenocorticotropic hormone test | ||
Adrenal gland tumour | CT | ||
Congenital leptin deficiency | Leptin ELISA | ||
Prohormone convertase deficiency | Oral glucose tolerance test, proinsulin ELISA | ||
Patient 2 | 1 y 11 m | Hypercortisolism | Cortisol profile |
Hypothyroidism | Laboratory | ||
Chromosome aberrations | Chromosome analysis | ||
Insulinoma | Blood glucose profile | ||
Prader-Willi syndrome | MS-MLPA | ||
Pseudohypoparathyroidism | Laboratory values and radiography | ||
Brain tumour/brain malformation | CT | ||
Glycogenosis type I | Clinical examinations | ||
2 y 9 m | Brain tumour/brain malformation | MRI | |
Hypothalamus tumour | MRI | ||
Prader-Willi syndrome | MS-MLPA | ||
5 y 6 m | Eating disorders | Psychological examinations | |
8 y 11 m | Growth hormone deficiency | l-Arginine and insulin-tolerance tests | |
9 y 3 m | Anterior pituitary insufficiency | Corticotropin-releasing hormone stimulation test and thyrotropin-releasing hormone stimulation test | |
Brain tumour/brain malformation | MRI | ||
11 y 9 m | Pituitary tumour | MRI | |
12 y 2 m | Disorder of the hypothalamic-pituitary-adrenal axis | Combined pituitary stimulation test | |
Adrenal insufficiency | Adrenocorticotropin stimulation test |
CT computer tomography, ELISA enzyme-linked immunosorbent assay, MS-MLPA methylation-specific multiplex ligation-dependent probe amplification, MRI magnetic resonance imaging